Confocal endomicroscopy in diagnosis of intestinal chronic graft-versus-host disease

Kathrin Rieger1, Ute Günther2, Ulrike Erben2

  • 1Center of Tumor Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Insights

Confocal endomicroscopy (CEM) shows promise for diagnosing intestinal chronic graft-versus-host disease (cGvHD), detecting esophageal involvement but missing fibrosis. Its sensitivity for cGvHD is lower than for acute GvHD (aGvHD).

Area of Science:

  • Gastroenterology
  • Transplantation Medicine
  • Medical Imaging

Background:

  • Graft-versus-host disease (GvHD) is a significant complication following allogeneic stem cell transplantation.
  • Confocal laser endomicroscopy (CEM) has demonstrated high sensitivity in detecting acute GvHD (aGvHD) in the intestine.
  • The diagnostic utility of CEM for intestinal chronic GvHD (cGvHD) requires further evaluation.

Purpose of the Study:

  • To assess the diagnostic value of CEM in identifying intestinal cGvHD.
  • To compare the performance of CEM in cGvHD versus aGvHD.
  • To evaluate CEM's ability to detect specific histological features of cGvHD in vivo.

Main Methods:

  • A pilot study involving 20 patients with confirmed cGvHD and 20 patients with suspected aGvHD.
  • CEM performed via gastroscopy and sigmoidoscopy, using fluorescein and acriflavine contrast agents.
  • Histopathological analysis of H&E-stained biopsy samples from the intestinal tract to correlate with CEM findings.

Main Results:

  • CEM detected esophageal cGvHD in 3 patients and showed moderate correlation with histology (r=0.64).
  • CEM sensitivity for cGvHD was 40%, significantly lower than the 70% observed for aGvHD.
  • CEM failed to detect stroma fibrosis, a key feature of cGvHD, while apoptosis assessment showed partial concordance with histology.

Conclusions:

  • CEM is a useful noninvasive tool for diagnosing intestinal aGvHD and aids in detecting esophageal cGvHD.
  • CEM alone is insufficient for a comprehensive diagnosis of intestinal cGvHD, particularly regarding fibrosis.
  • CEM facilitates targeted biopsy acquisition in patients with suspected cGvHD.